Denosumab

Results: 175



#Item
91Microsoft Word - osteoporosis-int.doc

Microsoft Word - osteoporosis-int.doc

Add to Reading List

Source URL: www.hivclinic.ca

Language: English - Date: 2013-11-04 13:43:31
92NOVA SCOTIA PROVINCIAL PHARMACARE PROGRAMS Request for Coverage of Osteoporosis Therapy PATIENT INFORMATION PATIENT SURNAME  PATIENT GIVEN NAME

NOVA SCOTIA PROVINCIAL PHARMACARE PROGRAMS Request for Coverage of Osteoporosis Therapy PATIENT INFORMATION PATIENT SURNAME PATIENT GIVEN NAME

Add to Reading List

Source URL: novascotia.ca

Language: English - Date: 2014-01-06 14:13:30
93Division: Pharmacy Services  Subject: Prior Authorization Criteria Original Development Date: Original Effective Date:

Division: Pharmacy Services Subject: Prior Authorization Criteria Original Development Date: Original Effective Date:

Add to Reading List

Source URL: www.ahca.myflorida.com

Language: English - Date: 2012-06-25 14:43:19
94962  Zoledronic Acid Delays the Onset of Skeletal-Related Events and Progression of Skeletal Disease in Patients with Advanced Renal Cell Carcinoma Allan Lipton, M.D.1

962 Zoledronic Acid Delays the Onset of Skeletal-Related Events and Progression of Skeletal Disease in Patients with Advanced Renal Cell Carcinoma Allan Lipton, M.D.1

Add to Reading List

Source URL: www.kidneycancercanada.ca

Language: English - Date: 2012-11-27 15:44:00
95PRODUCT MONOGRAPH  XGEVA Pr

PRODUCT MONOGRAPH XGEVA Pr

Add to Reading List

Source URL: www.amgen.ca

Language: English - Date: 2014-10-10 12:55:23
96Zoledronic Acid Versus Placebo in the Treatment of Skeletal Metastases in Patients With Lung Cancer and Other Solid Tumors: A Phase III, Double-Blind, Randomized Trial—The Zoledronic Acid Lung Cancer and Other Solid Tu

Zoledronic Acid Versus Placebo in the Treatment of Skeletal Metastases in Patients With Lung Cancer and Other Solid Tumors: A Phase III, Double-Blind, Randomized Trial—The Zoledronic Acid Lung Cancer and Other Solid Tu

Add to Reading List

Source URL: www.kidneycancercanada.ca

Language: English - Date: 2012-11-27 15:44:03
97Division: Pharmacy Services  Subject: Prior Authorization Criteria Original Development Date: Original Effective Date:

Division: Pharmacy Services Subject: Prior Authorization Criteria Original Development Date: Original Effective Date:

Add to Reading List

Source URL: www.fdhc.state.fl.us

Language: English - Date: 2012-06-25 14:31:43
98Program # Abstract Title  2011 SABCS Disclosure Report F. Name M. Name L. Name

Program # Abstract Title 2011 SABCS Disclosure Report F. Name M. Name L. Name

Add to Reading List

Source URL: www.sabcs.org

Language: English - Date: 2012-02-27 11:38:46
99Skeletal system / Bisphosphonates / Osteopathies / Chemical pathology / Alendronic acid / Merck / Bisphosphonate / Osteoporosis / Denosumab / Medicine / Biology / Health

TO THE INSURANCE COMPANY OF --------------------------- My patient informed me that you have refused to pay for markers of bone resorption (collagen crosslinks) because you claim that these tests are "experimental". T

Add to Reading List

Source URL: courses.washington.edu

Language: English - Date: 2012-03-23 17:01:02
100Division: Pharmacy Services  Subject: Prior Authorization Criteria Original Development Date: Original Effective Date:

Division: Pharmacy Services Subject: Prior Authorization Criteria Original Development Date: Original Effective Date:

Add to Reading List

Source URL: www.ahca.myflorida.com

Language: English - Date: 2012-06-25 14:31:43